Diplomat Pharmacy is now filling prescriptions for Cuvitru, immune globulin subcutaneous, which was recently approved by the Food and Drug Administration.
Cuvitru is indicated as a replacement therapy for primary humoral immunodeficiency in adult and pediatric patients 2 years and older.
“Cuvitru is an important treatment for patients with unmet needs,” he added.
There are more than 300 primary immunodeficiency disorders, in which part of the body’s immune system is missing or does not function properly. Normally, the immune system protects the body from pathogenic microorganisms like bacteria, viruses, and fungi, which can cause infectious diseases. When any part of a person’s immune system is absent or dysfunctional, that person is susceptible to and may take longer to recover from infections.